Alerts will be sent to your verified email
Verify EmailVANTABIO
|
Vanta Bioscience
|
MIG Media Neurons
|
FGP
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.45 % | n/a | 6.8 % |
|
5yr average Equity Multiplier
|
5.0 | n/a | 1.09 |
|
5yr Average Asset Turnover Ratio
|
0.09 | n/a | 0.14 |
|
5yr Avg Net Profit Margin
|
-72.95 % | n/a | 62.06 % |
|
Price to Book
|
0.0 | n/a | 3.8 |
|
P/E
|
166.54 | n/a | 180.06 |
|
5yr Avg Cash Conversion Cycle
|
391.21 Days | n/a | -36.31 Days |
|
Inventory Days
|
550.05 Days | n/a | 0.0 |
|
Days Receivable
|
524.58 Days | n/a | 0.0 |
|
Days Payable
|
1235.82 Days | n/a | 422.27 Days |
|
5yr Average Interest Coverage Ratio
|
-0.2 | n/a | -1325.47 |
|
5yr Avg ROCE
|
-3.41 % | n/a | -3.05 % |
|
5yr Avg Operating Profit Margin
|
-33.08 % | n/a | -250.62 % |
|
5 yr average Debt to Equity
|
3.47 | n/a | 0.0 |
|
5yr CAGR Net Profit
|
n/a | n/a | -40.64 % |
|
5yr Average Return on Assets
|
-3.03 % | n/a | 1.45 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.81 % | n/a | 43.59 % |
|
Share Pledged by Promoters
|
0.0 | n/a | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
2.88 % | n/a | 2.14 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | n/a | 0.0 |
|
Vanta Bioscience
|
MIG Media Neurons
|
FGP
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
-
|